PharMerica Sued Over Rebuffed $441M Omnicare Deal
Pharmacy management services provider PharMerica Corp. was hit Monday with a putative class action claiming a poison pill defense the company put in place to resist pharmaceutical supplier Omnicare Inc.'s $440.8...To view the full article, register now.
Already a subscriber? Click here to view full article